Diagnostic and therapeutic approaches in Italian hospitals: Adjuvant and metastatic therapy in melanoma

Vanna Chiarion-Sileni; Michele Guida; Antonella Romanini; Maria Grazia Bernengo; Paolo Ascierto; Paola Queirolo; Mario Mandalà; Michele Maio; Virginia Ferraresi; Ignazio Stanganelli; Alessandro Testori; Ruggero Ridolfi

doi:10.1159/000348870

Diagnostic and therapeutic approaches in Italian hospitals: Adjuvant and metastatic therapy in melanoma

Vanna Chiarion-Sileni, Michele Guida, Antonella Romanini, Maria Grazia Bernengo, Paolo Ascierto, Paola Queirolo, Mario Mandalà, Michele Maio, Virginia Ferraresi, Ignazio Stanganelli, Alessandro Testori, Ruggero Ridolfi

Research output: Contribution to journal › Article › peer-review

Abstract

Melanoma incidence and mortality rates are rising in Italy, indicating that more effective treatments are required both in the adjuvant and metastatic settings. We analyzed clinical practices in the adjuvant and metastatic settings by conducting a nationwide survey of clinicians responsible for managing melanoma treatment and follow-up in a representative sample of Italian hospitals. 95% of participating hospitals completed the panel of questions on adjuvant and metastatic treatment, making it likely that these results give a realistic picture of treatment and follow-up of melanoma patients in Italy. In low-volume hospitals (

Original language	English
Pages (from-to)	22-27
Number of pages	6
Journal	Dermatology
Volume	226
Issue number	SUPPL.1
DOIs	https://doi.org/10.1159/000348870
Publication status	Published - May 2013

Keywords

Adjuvant treatment
Chemotherapy
Interferon
Melanoma

ASJC Scopus subject areas

Dermatology

Access to Document

10.1159/000348870

Cite this

@article{817153d8e45b4d8f9c8ff5e0f3cdedbc,

title = "Diagnostic and therapeutic approaches in Italian hospitals: Adjuvant and metastatic therapy in melanoma",

abstract = "Melanoma incidence and mortality rates are rising in Italy, indicating that more effective treatments are required both in the adjuvant and metastatic settings. We analyzed clinical practices in the adjuvant and metastatic settings by conducting a nationwide survey of clinicians responsible for managing melanoma treatment and follow-up in a representative sample of Italian hospitals. 95% of participating hospitals completed the panel of questions on adjuvant and metastatic treatment, making it likely that these results give a realistic picture of treatment and follow-up of melanoma patients in Italy. In low-volume hospitals (",

keywords = "Adjuvant treatment, Chemotherapy, Interferon, Melanoma",

author = "Vanna Chiarion-Sileni and Michele Guida and Antonella Romanini and Bernengo, {Maria Grazia} and Paolo Ascierto and Paola Queirolo and Mario Mandal{\`a} and Michele Maio and Virginia Ferraresi and Ignazio Stanganelli and Alessandro Testori and Ruggero Ridolfi",

year = "2013",

month = may,

doi = "10.1159/000348870",

language = "English",

volume = "226",

pages = "22--27",

journal = "Dermatology",

issn = "1018-8665",

publisher = "S. Karger AG",

number = "SUPPL.1",

}

TY - JOUR

T1 - Diagnostic and therapeutic approaches in Italian hospitals

T2 - Adjuvant and metastatic therapy in melanoma

AU - Chiarion-Sileni, Vanna

AU - Guida, Michele

AU - Romanini, Antonella

AU - Bernengo, Maria Grazia

AU - Ascierto, Paolo

AU - Queirolo, Paola

AU - Mandalà, Mario

AU - Maio, Michele

AU - Ferraresi, Virginia

AU - Stanganelli, Ignazio

AU - Testori, Alessandro

AU - Ridolfi, Ruggero

PY - 2013/5

Y1 - 2013/5

N2 - Melanoma incidence and mortality rates are rising in Italy, indicating that more effective treatments are required both in the adjuvant and metastatic settings. We analyzed clinical practices in the adjuvant and metastatic settings by conducting a nationwide survey of clinicians responsible for managing melanoma treatment and follow-up in a representative sample of Italian hospitals. 95% of participating hospitals completed the panel of questions on adjuvant and metastatic treatment, making it likely that these results give a realistic picture of treatment and follow-up of melanoma patients in Italy. In low-volume hospitals (

AB - Melanoma incidence and mortality rates are rising in Italy, indicating that more effective treatments are required both in the adjuvant and metastatic settings. We analyzed clinical practices in the adjuvant and metastatic settings by conducting a nationwide survey of clinicians responsible for managing melanoma treatment and follow-up in a representative sample of Italian hospitals. 95% of participating hospitals completed the panel of questions on adjuvant and metastatic treatment, making it likely that these results give a realistic picture of treatment and follow-up of melanoma patients in Italy. In low-volume hospitals (

KW - Adjuvant treatment

KW - Chemotherapy

KW - Interferon

KW - Melanoma

UR - http://www.scopus.com/inward/record.url?scp=84878852031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878852031&partnerID=8YFLogxK

U2 - 10.1159/000348870

DO - 10.1159/000348870

M3 - Article

C2 - 23736267

AN - SCOPUS:84878852031

VL - 226

SP - 22

EP - 27

JO - Dermatology

JF - Dermatology

SN - 1018-8665

IS - SUPPL.1

ER -

Diagnostic and therapeutic approaches in Italian hospitals: Adjuvant and metastatic therapy in melanoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this